Literature DB >> 14764787

Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.

Linda J Woodhouse1, Nidhi Gupta, Meenakshi Bhasin, Atam B Singh, Robert Ross, Jeffrey Phillips, Shalender Bhasin.   

Abstract

Testosterone supplementation reduces total body adipose tissue (AT), but we do not know whether the effects are uniformly distributed throughout the body or are region specific, or whether they are dose related. We determined the effects of graded doses of testosterone on regional AT distribution in 54 healthy men (18-35 yr) in a 20-wk, randomized, double-blind study of combined treatment with GnRH agonist plus one of five doses (25, 50, 125, 300, or 600 mg/wk) of testosterone enanthate (TE). Total body, appendicular, and trunk AT and lean body mass were measured by dual-energy x-ray absorptiometry, and sc, intermuscular, and intraabdominal AT of the thigh and abdomen were measured by magnetic resonance imaging. Treatment regimens resulted in serum nadir testosterone concentrations ranging from subphysiological to supraphysiological levels. Dose-dependent changes in AT mass were negatively correlated with TE dose at all sites and were equally distributed between the trunk and appendices. The lowest dose was associated with gains in sc, intermuscular, and intraabdominal AT, with the greatest percent increase occurring in the sc stores. At the three highest TE doses, thigh intermuscular AT volume was significantly reduced, with a greater percent loss in intermuscular than sc depots, whereas intraabdominal AT stores remained unchanged. In conclusion, changes in testosterone concentrations in young men are associated with dose-dependent and region-specific changes in AT and lean body mass in the appendices and trunk. Lowering testosterone concentrations below baseline increases sc and deep AT stores in the appendices and abdomen, with a greater percent increase in sc depots. Conversely, elevating testosterone concentrations above baseline induces a greater loss of AT from the smaller, deeper intermuscular stores of the thigh.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764787     DOI: 10.1210/jc.2003-031492

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 3.  Circulating androgens in women: exercise-induced changes.

Authors:  Carina Enea; Nathalie Boisseau; Marie Agnès Fargeas-Gluck; Véronique Diaz; Benoit Dugué
Journal:  Sports Med       Date:  2011-01-01       Impact factor: 11.136

4.  Gonadal steroids and body composition, strength, and sexual function in men.

Authors:  Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

Review 5.  [Therapy of male hypogonadism].

Authors:  M Zitzmann
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

6.  Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes.

Authors:  Vandana Gupta; Shalender Bhasin; Wen Guo; Rajan Singh; Rika Miki; Pratibha Chauhan; Karen Choong; Tamara Tchkonia; Nathan K Lebrasseur; John N Flanagan; James A Hamilton; Jason C Viereck; Navjot S Narula; James L Kirkland; Ravi Jasuja
Journal:  Mol Cell Endocrinol       Date:  2008-08-28       Impact factor: 4.102

7.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

8.  Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial.

Authors:  T Gagliano-Jucá; E R Tang; S Bhasin; K M Pencina; S Anderson; H Jara; Z Li; K Melamud; S L Coleman; A Aakil; R R Almeida; G Huang; T G Travison; T W Storer; S Basaria
Journal:  Andrology       Date:  2017-07-13       Impact factor: 3.842

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

10.  High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.

Authors:  Andrea D Coviello; Susan Sam; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.